Early subclinical rejection as a risk factor for late chronic humoral rejection

Transplantation

Volumn 93, Issue 1, 2012, Pages 41-46

  Moreso, Francesc ^a   Carrera, Marta ^b   Goma, Montse ^b   Hueso, Miguel ^b   Sellares, Joana ^b   Martorell, Jaume ^c   Grinyó, Josep M ^b   Serón, Daniel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Interstitial fibrosis; Protocol biopsies; Renal transplantation; Subclinical rejection; Transplant glomerulopathy

Indexed keywords

CREATININE;

ADULT; ARTICLE; CHRONIC GRAFT REJECTION; CHRONIC HUMORAL REJECTION; CLINICAL PROTOCOL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FIBROSING ALVEOLITIS; GLOMERULONEPHRITIS; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY ATROPHY; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POLYOMA VIRUS; POLYOMA VIRUS NEPHROPATHY; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; REOPERATION; RISK FACTOR; T CELL MEDIATED REJECTION;

ADULT; BIOPSY; FEMALE; GLOMERULONEPHRITIS; GRAFT REJECTION; HUMANS; IMMUNITY, HUMORAL; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84655163829     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31823bb647     Document Type: Article

References (31)

1. Rush DN, Jeffery JR, Gough J. Sequential protocol biopsies in renal transplant patients. Transplantation 1995; 59: 511.
2. Serón D, Moreso F, Bover J, et al. protocol renal allograft biopsies and graft outcome. Kidney Int 1997; 51: 310.
3. Nankivell BJ, Borrows RJ, Fung CLS, et al. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 2004; 78: 242.
4. Roberts IS, Reddy S, Russell C, et al. Subclinical rejection and borderline changes in early protocol biopsies specimens after renal transplantation. Transplantation 2004; 77: 1194.
5. Serón D, O'Valle F, Moreso F, et al. Subclinical rejection, a condition of an emergent interest. Nefrologia 2006; 26(suppl 7): 3.
6. Nickerson P, Jeffery J, Gough J, et al. Effect of increasing baseline immunosuppression on the prevalence of subclinical rejection: A pilot study. J Am Soc Nephrol 1999; 10: 1801.
7. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
8. Solez K, Colvin RB, Racusen LC et al. Banff '05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518.
9. Choi BS, Shin MJ, Sjin SJ, et al. Clinical significance of an early protocol biopsy in living-donor renal transplantation: Ten-year experience at a single center. Am J Transplant 2005; 5: 1354.
10. Shishido S, Asanuma H, Nakai H, et al. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 2003; 14: 1046.
11. Cosio FG, Grande JP, Wadei H, et al. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005; 5: 2464.
12. Moreso F, Ibernon M, Goma M, et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006; 6: 747.
13. Mao Q, Terasaki PI, Cai J, et al. Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant 2007; 7: 864.
14. Lachmann N, Terasaki PI, Budde K, et al. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex postrasplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 2009; 87: 1505.
15. Mauiyyedi S, Pelle PD, Saidman S, et al. Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J AmSoc Nephrol 2001; 12: 574.
16. Sis B, Campbell PM, Mueller T, et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007; 7: 1743.
17. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520.
18. Gloor JM, Sethi S, Stegall MD, et al. Transplant glomerulopathy: Subclinical incidence and association with antibody.AmJ Transplant 2007; 7: 2124.
19. Wieczorek G, Bigaud M, Menninger K, et al. Acute and chronic vascular rejection in nonhuman primate kidney transplantation.AmJ Transplant 2006; 6: 1285.
20. Gouldesbrough DR, Axelsen RA. Arterial endothelialitis in chronic renal allograft rejection: A histopathological and immunocytochemical study. Nephrol Dial Transplant 1994; 9: 35.
21. Smith RN, Kawai T, Boskovic S, et al. Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys. Am J Transplant 2008; 8: 1662.
22. Maryniak RK, First MR, Weiss MA. Transplant glomerulopathy: Evolution of morphologically distinct changes. Kidney Int 1985; 27: 799.
23. Haas M, Montgomery RA, Segev DL, et al. Subclinical acute antibodymediated rejection in positive crossmatch renal allografts. Am J Transplant 2007; 7: 576.
24. Kraus ES, Parekh RS, Oberai P, et al. Subclinical rejection in stable positive crossmatch kidney transplant patients: Incidence and correlations. Am J Transplant 2009; 9: 1826.
25. Ashton-Chess J, Dugast E, Colvin RB, et al. Regulator, effector, and cytototxic T cells profiles in long-term kidney transplant patients. J Am Soc Nephrol 2009; 20: 1113.
26. Halloran PF, de Freitas DG, Einecke G, et al. The molecular phenotype of kidney transplants. Am J Transplant 2010; 10: 2215.
27. Homs S, Mansour H, Desvaux D, et al. Predominant Th1 and cytotoxic phenotype in biopsies from renal transplant recipients with transplant glomerulopathy. Am J Transplant 2009; 9: 1230.
28. Nickeleit V, Andreoni K. The classification and treatment of antibody mediated renal allograft injury: Where do we stand? Kidney Int 2007; 71: 7.
29. Moreso F, Serón D, Carrera M, et al. Baseline immunosuppression is associated with histological findings in early protocol biopsies. Transplantation 2004; 78: 1064.
30. Rush D, Arlen D, Boucher A, et al. Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: A randomized study. Am J Transplant 2007; 7: 2538.
31. Kieran N, Wang X, Perkins J, et al. Combination of peritubular C4d and transplant glomerulopathy predicts late renal allograft failure.JAm Soc Nephrol 2009; 20: 2260.